Found 9 results
Author [ Title(Desc)] Type Year
Filters: Keyword is Mycobacterium avium-intracellulare Infection  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
Y. Yamazaki, Danelishvili, L., Wu, M., Hidaka, E., Katsuyama, T., Stang, B., Petrofsky, M., Bildfell, R., and Bermudez, L. E., “The ability to form biofilm influences Mycobacterium avium invasion and translocation of bronchial epithelial cells.”, Cell Microbiol, vol. 8, no. 5, pp. 806-14, 2006.
L. E. Bermudez, Petrofsky, M., Kolonoski, P., and Young, L. S., “An animal model of Mycobacterium avium complex disseminated infection after colonization of the intestinal tract.”, The Journal of infectious diseases, vol. 165, no. 1, pp. 75-9, 1992.
M
L. E. Bermudez, Wagner, D., and Sosnowska, D., “Mechanisms of Mycobacterium avium pathogenesis.”, Archivum immunologiae et therapiae experimentalis, vol. 48, no. 6, pp. 521-7, 2000.
C. B. Inderlied, Kemper, C. A., and Bermudez, L. E., “The Mycobacterium avium complex.”, Clinical microbiology reviews, vol. 6, no. 3, pp. 266-310, 1993.
L. Danelishvili and Bermudez, L. E., “Mycobacterium avium MAV_2941 mimics phosphoinositol-3-kinase to interfere with macrophage phagosome maturation.”, Microbes Infect, vol. 17, no. 9, pp. 628-37, 2015.
J. Early, Fischer, K. A., and Bermudez, L. E., “Mycobacterium avium uses apoptotic macrophages as tools for spreading.”, Microbial pathogenesis, vol. 50, no. 2, pp. 132-9, 2011.
P
L. S. Young, Bermudez, L. E., and Inderlied, C. B., “Practical issues in the antibiotic and immunotherapy of Mycobacterium avium disease in immunocompromised patients.”, Research in microbiology, vol. 145, no. 3, pp. 206-9, 1994.
R
L. Danelishvili and Bermudez, L. E., “Role of type I cytokines in host defense against Mycobacterium avium infection.”, Curr Pharm Des, vol. 9, no. 1, pp. 61-5, 2003.
T
L. E. Bermudez, Inderlied, C. B., Kolonoski, P., Wu, M., Aralar, P., and Young, L. S., “Telithromycin is active against Mycobacterium avium in mice despite lacking significant activity in standard in vitro and macrophage assays and is associated with low frequency of resistance during treatment.”, Antimicrobial agents and chemotherapy, vol. 45, no. 8, pp. 2210-4, 2001.